Search
Searching Content indexed under Food and Drugs Law by Michele Adelman ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
FDA And Amarin Pharma Reach Milestone Settlement Allowing Off-Label Drug Promotion
A milestone Settlement Agreement was reached March 8, 2016 between the Food and Drug Administration and Amarin Pharma, Inc. that expressly allows Amarin to promote its drug product, Vascepa®, for unapproved – i.e., "off-label" – uses.
United States
31 Mar 2016
2
A Low Dose Prescription: Criminal Prosecution Of Off-Label Drug Promotion
Drug company scientists discover that a rare debilitating disease may be treated with a drug licensed to treat an unrelated ailment.
United States
23 Jan 2008
Links to Result pages
 
1